DUOTAP: Routine Postdilation May Optimize THV Geometry, Hemodynamics

Routine postdilation with a balloon-expandable transcatheter heart valve (THV) optimized THV geometry and improved hemodynamic performance, without increasing procedure-related adverse events in patients with severe aortic stenosis (AS), according to results from the DUOTAP trial presented at TCT 2026 and simultaneously published in JAMA Cardiology.

SIRONA: Sirolimus- vs. Paclitaxel-Coated Balloon Angioplasty at 3 Years

Comparing sirolimus-coated balloon (SCB) and paclitaxel-coated balloon (PCB) angioplasty in patients with symptomatic femoropopliteal artery disease, no differences in walking capacity and health-related quality of life were noted; however, freedom from clinically driven target-lesion revascularization (TLR) was higher in the SCB group, according to three-year results from the SIRONA trial, presented at TCT 2026 and simultaneously published in JACC: Cardiovascular Interventions.

VERITAS and TRAVEL III: LAAO With Amulet 360; TTVR With LuX-Valve Plus System

Among patients who underwent left atrial appendage occlusion (LAAO) with the Amulet 360 device, complete LAA closure was observed in 96.3% of patients at one year with low rates of stroke and mortality, according to results from the VERITAS trial, presented at TCT 2026 and simultaneously published in JACC: Cardiovascular Interventions.